Zhonghong Pulin Medical Products300981.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 19, 2026, Zhonghong Pulin Medical Products (300981.SZ) trades at a P/E of 201.00x, P/B of 1.56x, P/S of 2.76x, and a dividend yield of 1.83%.
Longitudinal percentile comparison: P/E sits at the 97th percentile over the trailing 10Y window (vs. 85th percentile over 3Y); P/B sits at the 82nd percentile over the trailing 10Y window (vs. 98th percentile over 3Y); P/S sits at the 66th percentile over the trailing 10Y window (vs. 89th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 91st percentile within its industry and the 91st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.83%, ranking at the 18th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 15.4 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Zhonghong Pulin Medical Products operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300981 · SZSE: 300981 · 300981
Want the full picture on whether Zhonghong Pulin Medical Products (300981.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 201.00 | ||||||
| P/B (MRQ) | 1.56 | ||||||
| P/S (TTM) | 2.76 | ||||||
| Dividend Yield | 1.83% | ||||||
| Buyback + Div Yield | 1.83% |